A 72-year-old man with a history of hypertension and smoking presents with acute severe chest pain radiating to the back. Imaging confirms an acute Type A aortic dissection with haemodynamic instability. Prior to surgical intervention, which agent is the first-line drug for acute blood pressure and heart rate control?

Explanation

## Acute Type A Aortic Dissection — Pharmacological Stabilization ### Clinical Context Acute Type A aortic dissection (AAD) is a surgical emergency requiring immediate reduction of aortic shear stress to prevent propagation of the dissection flap. Unlike ruptured AAA (where permissive hypotension is acceptable), Type A dissection requires urgent surgical repair, and pre-operative stabilization must minimize dP/dt while maintaining adequate perfusion. ### The Sequential Approach: β-Blockade First, Then Vasodilation **Key Point:** The gold standard for acute aortic dissection is **sequential therapy**: β-blockade FIRST (to reduce dP/dt and heart rate), followed by vasodilation (to lower systolic BP) if needed. This sequence is critical because vasodilation alone triggers reflex tachycardia, worsening aortic shear stress. **High-Yield:** The rationale: 1. **β-Blockade (esmolol or labetalol)** reduces contractility and heart rate, lowering dP/dt — the primary driver of dissection propagation. 2. **Vasodilation (nitroprusside or hydralazine)** is added only AFTER achieving adequate β-blockade, to further reduce systolic BP to target 100–120 mmHg and mean arterial pressure 60–75 mmHg. ### Why Esmolol + Nitroprusside? | Component | Agent | Rationale | |-----------|-------|----------| | **β-blockade** | Esmolol | Rapid onset (1 min), short half-life (9 min), easily titratable IV infusion (0.5–1 mg/kg/min); allows quick dose adjustment if hypotension develops | | **Vasodilation** | Sodium nitroprusside | Potent, rapidly titratable IV agent (0.5–10 μg/kg/min); achieves target BP within minutes; allows precise control | | **Target** | Both agents | Heart rate 60 bpm, SBP 100–120 mmHg, MAP 60–75 mmHg | **Clinical Pearl:** Esmolol is preferred over labetalol in acute dissection because its ultra-short half-life allows rapid titration and reversal if hypotension occurs. Labetalol can be used as an alternative if IV esmolol is unavailable, but esmolol offers superior control in the acute phase. ### Why NOT the Other Options? **Warning:** Hydralazine monotherapy (option B) or calcium channel blocker monotherapy (option C) without prior β-blockade will cause reflex tachycardia and increased contractility, worsening dP/dt and risking dissection propagation. **Warning:** Alpha-blocker first (option D) is incorrect. The α-first approach is used in phaeochromocytoma (to prevent hypertensive crisis from catecholamine release), NOT in aortic dissection. In dissection, β-blockade must precede any vasodilation. ### Mnemonic for Dissection Drug Sequence **"BEAT the Dissection"** = **B**eta-blocker first, then **E**xpand (vasodilate), **A**im for target **T**herapy (HR 60, SBP 100–120).